Liftstream is an executive search recruitment company in the life sciences sector
KalVista Pharmaceuticals adds $33m and Directors in Series B round
KalVista Pharmaceuticals, a research-led pharmaceutical company, today announced it has raised $33 million in a Series B financing to support its research and clinical development programs. KalVista will use the funds to advance its proprietary portfolio of plasma kallikrein inhibitors for treating diabetic macular edema (DME) and hereditary angioedema (HAE). Alongside the existing investors, Novo A/S and SV Life Sciences, the round included additional international healthcare investors experienced in plasma kallikrein targeted mechanisms led by RA Capital Management and including Longwood Fund and Venrock.
Posted in M&A Finance and Funding
Tagged Board of Directors, Boston Biotech, KalVista, London Biotech, Novo A/S, Series B, SV Life Sciences
Leave a comment